These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8171869)

  • 1. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.
    Diabetologia; 1994 Mar; 37(3):278-85. PubMed ID: 8174842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N; Stephenson JM; Fuller JH
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].
    Fröhlich-Reiterer EE; Borkenstein MH
    Wien Med Wochenschr; 2010 Aug; 160(15-16):414-8. PubMed ID: 20812053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    De Meulemeester J; Charleer S; Visser MM; De Block C; Mathieu C; Gillard P
    Diabetologia; 2024 Aug; 67(8):1527-1535. PubMed ID: 38787436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Physical Activity on Glycemic Control and Prevalence of Cardiovascular Risk Factors in Adults With Type 1 Diabetes: A Cross-sectional Multicenter Study of 18,028 Patients.
    Bohn B; Herbst A; Pfeifer M; Krakow D; Zimny S; Kopp F; Melmer A; Steinacker JM; Holl RW;
    Diabetes Care; 2015 Aug; 38(8):1536-43. PubMed ID: 26015557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
    Williams KV; Becker DJ; Orchard TJ; Costacou T
    J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
    Tesfaye S; Stevens LK; Stephenson JM; Fuller JH; Plater M; Ionescu-Tirgoviste C; Nuber A; Pozza G; Ward JD
    Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
    Veglio M; Borra M; Stevens LK; Fuller JH; Perin PC
    Diabetologia; 1999 Jan; 42(1):68-75. PubMed ID: 10027581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.